nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0467	0.055	CcSEcCtD
Sparfloxacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0419	0.276	CbGpPWpGaD
Sparfloxacin—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0382	0.045	CcSEcCtD
Sparfloxacin—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0272	0.0321	CcSEcCtD
Sparfloxacin—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0233	CcSEcCtD
Sparfloxacin—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0205	CcSEcCtD
Sparfloxacin—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0161	0.019	CcSEcCtD
Sparfloxacin—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0181	CcSEcCtD
Sparfloxacin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0178	CcSEcCtD
Sparfloxacin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0169	CcSEcCtD
Sparfloxacin—Gout—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0168	CcSEcCtD
Sparfloxacin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0161	CcSEcCtD
Sparfloxacin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0142	CcSEcCtD
Sparfloxacin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0142	CcSEcCtD
Sparfloxacin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0119	0.014	CcSEcCtD
Sparfloxacin—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0132	CcSEcCtD
Sparfloxacin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.011	0.013	CcSEcCtD
Sparfloxacin—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0129	CcSEcCtD
Sparfloxacin—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0126	CcSEcCtD
Sparfloxacin—Injury—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0124	CcSEcCtD
Sparfloxacin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0121	CcSEcCtD
Sparfloxacin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0121	CcSEcCtD
Sparfloxacin—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0102	0.012	CcSEcCtD
Sparfloxacin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0102	0.012	CcSEcCtD
Sparfloxacin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00996	0.0117	CcSEcCtD
Sparfloxacin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00953	0.0112	CcSEcCtD
Sparfloxacin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00953	0.0112	CcSEcCtD
Sparfloxacin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00934	0.011	CcSEcCtD
Sparfloxacin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00917	0.0108	CcSEcCtD
Sparfloxacin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0091	0.0107	CcSEcCtD
Sparfloxacin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0105	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0104	CcSEcCtD
Sparfloxacin—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0104	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00872	0.0103	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00854	0.0101	CcSEcCtD
Sparfloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0084	0.0553	CbGpPWpGaD
Sparfloxacin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0082	0.00967	CcSEcCtD
Sparfloxacin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00815	0.00961	CcSEcCtD
Sparfloxacin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00782	0.00922	CcSEcCtD
Sparfloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00781	0.0515	CbGpPWpGaD
Sparfloxacin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00764	0.009	CcSEcCtD
Sparfloxacin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0075	0.00884	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00739	0.00872	CcSEcCtD
Sparfloxacin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00857	CcSEcCtD
Sparfloxacin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00725	0.00855	CcSEcCtD
Sparfloxacin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00725	0.00855	CcSEcCtD
Sparfloxacin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00715	0.00843	CcSEcCtD
Sparfloxacin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00711	0.00838	CcSEcCtD
Sparfloxacin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00704	0.00829	CcSEcCtD
Sparfloxacin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.007	0.00825	CcSEcCtD
Sparfloxacin—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00696	0.00821	CcSEcCtD
Sparfloxacin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00671	0.00791	CcSEcCtD
Sparfloxacin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0067	0.00789	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00785	CcSEcCtD
Sparfloxacin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00665	0.00783	CcSEcCtD
Sparfloxacin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0066	0.00778	CcSEcCtD
Sparfloxacin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00746	CcSEcCtD
Sparfloxacin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00624	0.00736	CcSEcCtD
Sparfloxacin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00598	0.00705	CcSEcCtD
Sparfloxacin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00592	0.00698	CcSEcCtD
Sparfloxacin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00677	CcSEcCtD
Sparfloxacin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00572	0.00674	CcSEcCtD
Sparfloxacin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00571	0.00673	CcSEcCtD
Sparfloxacin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00566	0.00667	CcSEcCtD
Sparfloxacin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00564	0.00665	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00551	0.0363	CbGpPWpGaD
Sparfloxacin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00644	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00638	CcSEcCtD
Sparfloxacin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00536	0.00632	CcSEcCtD
Sparfloxacin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00628	CcSEcCtD
Sparfloxacin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00526	0.0062	CcSEcCtD
Sparfloxacin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00617	CcSEcCtD
Sparfloxacin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00515	0.00607	CcSEcCtD
Sparfloxacin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00509	0.006	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00504	0.0332	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00504	0.0332	CbGpPWpGaD
Sparfloxacin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00585	CcSEcCtD
Sparfloxacin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00585	CcSEcCtD
Sparfloxacin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00585	CcSEcCtD
Sparfloxacin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00583	CcSEcCtD
Sparfloxacin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0049	0.00578	CcSEcCtD
Sparfloxacin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00485	0.00572	CcSEcCtD
Sparfloxacin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00565	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00476	0.00561	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00466	0.00549	CcSEcCtD
Sparfloxacin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00464	0.00547	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00542	CcSEcCtD
Sparfloxacin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00453	0.00535	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00433	0.00511	CcSEcCtD
Sparfloxacin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00507	CcSEcCtD
Sparfloxacin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00427	0.00504	CcSEcCtD
Sparfloxacin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00424	0.005	CcSEcCtD
Sparfloxacin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00499	CcSEcCtD
Sparfloxacin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00494	CcSEcCtD
Sparfloxacin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00488	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00412	0.0271	CbGpPWpGaD
Sparfloxacin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00407	0.0048	CcSEcCtD
Sparfloxacin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00407	0.0048	CcSEcCtD
Sparfloxacin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00462	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00459	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00382	0.0251	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00382	0.0251	CbGpPWpGaD
Sparfloxacin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00446	CcSEcCtD
Sparfloxacin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00443	CcSEcCtD
Sparfloxacin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00443	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00355	0.0234	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00355	0.0234	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00413	CcSEcCtD
Sparfloxacin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00402	CcSEcCtD
Sparfloxacin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00397	CcSEcCtD
Sparfloxacin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00384	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00316	0.0208	CbGpPWpGaD
Sparfloxacin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00371	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00314	0.0207	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00314	0.0207	CbGpPWpGaD
Sparfloxacin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00357	CcSEcCtD
Sparfloxacin—Rash—Hydrochlorothiazide—nephrolithiasis	0.003	0.00354	CcSEcCtD
Sparfloxacin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.003	0.00353	CcSEcCtD
Sparfloxacin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00298	0.00351	CcSEcCtD
Sparfloxacin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00333	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0028	0.0184	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00256	0.0169	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00256	0.0169	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0023	0.0151	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0023	0.0151	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00205	0.0135	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00194	0.0128	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00194	0.0128	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00187	0.0123	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00187	0.0123	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0018	0.0119	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0018	0.0119	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00161	0.0106	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00161	0.0106	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00142	0.00934	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00142	0.00934	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00132	0.00869	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00132	0.00869	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00128	0.00847	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00118	0.00774	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00118	0.00774	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00108	0.00711	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00108	0.00711	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000962	0.00634	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00094	0.00619	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00088	0.0058	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00088	0.0058	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000667	0.00439	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000667	0.00439	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00062	0.00408	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00062	0.00408	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000553	0.00364	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000553	0.00364	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000442	0.00291	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000383	0.00252	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000341	0.00225	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.00029	0.00191	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APRT—nephrolithiasis	0.00029	0.00191	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000207	0.00136	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000187	0.00123	CbGpPWpGaD
